Log in to save to my catalogue

Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy

Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10232004

Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Current therapies for Fabry disease are based on reversing intracellular accumulation of globotriaosylceramide (Gb3) by enzyme replacement therapy (ERT) or chaperone-mediated stabilization of the defective enzyme, thereby alleviating lysosomal dysfunction. However, their effect in the reversal of end-organ damage, like kidney injury and chronic kid...

Alternative Titles

Full title

Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10232004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10232004

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI157782

How to access this item